All Posts By

Smartkarma Daily Briefs

Daily Brief ESG: The Postponement of the Parent-Subsidiary Listing Issue Provides Further Investment Opportunities and more

By | Daily Briefs, ESG

In today’s briefing:

  • The Postponement of the Parent-Subsidiary Listing Issue Provides Further Investment Opportunities


The Postponement of the Parent-Subsidiary Listing Issue Provides Further Investment Opportunities

By Aki Matsumoto

  • The dissolution of parent-subsidiary listing was achieved through the sale of a portion of the listed subsidiary’s equity interest. The postponement of this issue is noted as an investment opportunity.
  • The status change of the listed subsidiary doesn’t address concerns regarding the interests of the subsidiary’s minority shareholders, nor does it implement restructuring of the parent company’s entire business portfolio.
  • While investors are disappointed that the problem has been postponed, it also means that there are still many investment opportunities remaining, including for listed affiliates.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief ECM: Chery Auto Pre-IPO – The Negatives – Small NEV Portfolio and more

By | Daily Briefs, ECM

In today’s briefing:

  • Chery Auto Pre-IPO – The Negatives – Small NEV Portfolio
  • Busy Ming IPO: Hyper Growth and Solid Profitability, Largest Snack and Beverage Retailer in China
  • Jiangsu Hengrui Pharma H Share Listing: The Investment Case
  • CATL A/H Listing – PHIP Updates and Updated Thoughts on A/H Premium
  • Sagility India IPO Lockup – US$1.5bn Lockup Release; PE Promoter Will Have to Trim for Free-Float
  • Initial Thoughts on the Musinsa IPO
  • Pre-IPO Xuanzhu Biopharmaceutical- Outdated Pipelines Are Difficult to Bring Good Investment Returns
  • Axbio (安序源) Pre-IPO: First Take of the Deal


Chery Auto Pre-IPO – The Negatives – Small NEV Portfolio

By Sumeet Singh

  • Chery Automobile is looking to raise about US$1bn in its upcoming Hong Kong IPO.
  • Chery Auto is a Chinese passenger vehicle company which designs, develops, manufactures and sells passenger vehicles, including internal combustion engine vehicles and new energy vehicles, both domestically and overseas.
  • In this note, we talk about the not-so-positive aspects of the deal.

Busy Ming IPO: Hyper Growth and Solid Profitability, Largest Snack and Beverage Retailer in China

By Andrei Zakharov

  • Busy Ming Group, “a snack brand for the people” and the largest snack and beverage chain retailer in China, filed for an IPO in Hong Kong.
  • The fast-growing retailer was backed by HongShan Capital, Gaorong Ventures, 5Y Capital, Haoxiangni Health Food, and Yanker Shop Food Co., among others.
  • Busy Ming Group is tapping into Gen Z and younger millennial consumers with playful branding and social media engagement.

Jiangsu Hengrui Pharma H Share Listing: The Investment Case

By Arun George

  • Jiangsu Hengrui Medicine (600276 CH), a leading Chinese pharmaceutical company, has filed its PHIP for an H Share listing to raise US$2 billion.     
  • Jiangsu Hengrui Pharmaceuticals (JHR HK) ranked first among Chinese pharma companies in revenue from NME drugs in 2023 and the number of commercialised NME drugs in 2024.
  • The investment case rests on its product portfolio, strong revenue growth, rising profitability, cash generation, strong balance sheet and undemanding valuation. 

CATL A/H Listing – PHIP Updates and Updated Thoughts on A/H Premium

By Sumeet Singh

  • Contemporary Amperex Technology (CATL) (300750 CH), one of the world’s largest battery solutions providers, aims to raise around US$5bn in its H-share listing.
  • CATL is the global leader in new energy vehicle battery solutions, in China and globally, as per SNE Research. Its A-shares have been listed since 2018.
  • We have looked at the company’s past performance and valuations in our earlier notes. In this note, we talk about its recent updates and provide updated thoughts on valuations.

Sagility India IPO Lockup – US$1.5bn Lockup Release; PE Promoter Will Have to Trim for Free-Float

By Akshat Shah

  • Sagility India (2058883D IN) (Sagility) raised around US$250m in its India IPO in Nov 2024. The lockup on its pre-IPO investors is set to expire soon.
  • Sagility is a pure-play healthcare focused solutions and services provider to Payers (U.S. health insurance companies), and Providers (primarily hospitals, physicians, and diagnostic and medical devices companies).
  • In this note, we will talk about the lockup dynamics, possible placement and updates since our last note.

Initial Thoughts on the Musinsa IPO

By Douglas Kim

  • Musinsa is getting ready to complete its IPO in 2H 2025. Musinsa is the top fashion online/mobile platform in Korea. 
  • The market value of Musinsa is expected to be about 5 trillion won which could be one of the largest IPOs in Korea this year. 
  • Musinsa had its best ever results in 2024 with sales of 1.2 trillion won (up 25.1% YoY), operating profit of 102.8 billion won, and net profit of 69.8 billion won.

Pre-IPO Xuanzhu Biopharmaceutical- Outdated Pipelines Are Difficult to Bring Good Investment Returns

By Xinyao (Criss) Wang

  • The main purpose for Sihuan to acquire Combio is to form a strong innovative drug business Xuanzhu and then make large capital gains from the subsequent spin-off and listing.
  • All the three Core Products need to face fierce competition, and their clinical data do not show obvious advantages to competing products, making them hard to stand out.
  • Based on the announcement on Nov.12, 2024, valuation of Xuanzhu was RMB8.5 billion. However, due to the lack of competitive pipelines and weak commercialization prospects, we think Xuanzhu is overvalued.

Axbio (安序源) Pre-IPO: First Take of the Deal

By Ke Yan, CFA, FRM

  • Axbio, a China-based technology company, is looking to raise at least USD 100 million via a Hong Kong listing. CICC and SPDB are the joint sponsors.
  • In this note, we took a quick look at the core products and key products, as well as its management team.
  • Although there are interesting takes from the prospectus, we are not convinced on the prospect of the deal yet.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Credit: Adani Ports – Earnings Flash – FY 2024-25 Results – Lucror Analytics and more

By | Credit, Daily Briefs

In today’s briefing:

  • Adani Ports – Earnings Flash – FY 2024-25 Results – Lucror Analytics
  • Lucror Analytics – Morning Views Asia


Adani Ports – Earnings Flash – FY 2024-25 Results – Lucror Analytics

By Leonard Law, CFA

  • Adani Ports and Special Economic Zone (APSEZ) has released FY 2024-25 results that were largely stable y-o-y.
  • Although cargo volume growth underperformed expectations, revenue rose 14% in line with projections, while the 16% EBITDA increase exceeded guidance.
  • APSEZ generated slightly positive FCF, and net adjusted leverage was stable at an acceptable 2.8x.

Lucror Analytics – Morning Views Asia

By Leonard Law, CFA

  • In today’s Morning Views publication we comment on developments of the following high yield issuers: International Container, Pakuwon Jati
  • In the US, the April ISM services index unexpectedly rose to 51.6 (50.2 e / 50.8 p). The new orders component expanded to 52.3 (50.3 e / 50.4 p), while employment increased to 49.0 (47.1 e / 46.2 p).
  • The prices paid component jumped to 65.1 (61.4 e / 60.9 p), the highest level since 2022. Separately, the April (final) S&P services PMI declined to 50.8 (51.2 e / 54.4 p), below the preliminary reading of 51.4. The composite PMI fell to 50.6 (53.5 p).

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Macro: HEM: Dovish Prices Deranged and more

By | Daily Briefs, Macro

In today’s briefing:

  • HEM: Dovish Prices Deranged
  • Steno Signals #195 – Wait, what? Did China just start buying Treasuries again?
  • Assessing Trump’s Shock and Awe Move in Apr 2025
  • Nextrade (NXT) Overview: History, Sharp Market Share Gains, and Key Differentiators
  • Overview #25 Implications of Stronger Asian Currencies
  • Asia base oils supply outlook: Week of 5 May
  • Vietnam – Hold Don’t Sell Down
  • Global base oils arb outlook: Week of 5 May
  • Global base oils margins outlook: Week of 5 May
  • Real Asset Chartbook Week #4: Still Interesting


HEM: Dovish Prices Deranged

By Phil Rush

  • Despite concerns, activity continues to be robust with stable manufacturing and tight labour markets.
  • There is a persistent issue of high underlying price and wage inflation.
  • The Bank of England’s rate cut ahead of the Federal Reserve is seen as highly irrational, as rates do not reflect the rebounding risk sentiment.

Steno Signals #195 – Wait, what? Did China just start buying Treasuries again?

By Andreas Steno

  • Morning from a sunny Copenhagen! Many pundits have (rightfully) struggled to find a coherent logic behind the Trump administration’s trade policy.
  • However, quietly—but increasingly noticeably—the administration is beginning to make progress on a few of the core objectives outlined in the so-called “Mar-a-Lago Accord.” This accord seeks to leverage the U.S. defense umbrella to compel major trade partners to accept:a weaker USD, and increased purchases of U.S. Treasuries (USTs) in exchange for continued security guarantees—  with tariffs serving as the primary tool in this negotiation strategy.
  • While this approach has clearly sparked outrage globally—and while one can certainly question the strategic coherence and execution—the first signs are emerging that suggest it might be achieving some of its intended effects.

Assessing Trump’s Shock and Awe Move in Apr 2025

By Kok Peng Chan

  • April 2025 saw extreme market volatility after President Trump announced sweeping reciprocal tariffs, mainly aimed at China.
  • Subsequent delays and complex exemptions fueled market swings, sparking fears of recession and inflation. First quarter 2025 US GDP contraction is not a trend.
  • Despite headline risks, deeper analysis suggests a more balanced global economy over the longer term. Both China and the US will do whatever it takes to avoid a recession

Nextrade (NXT) Overview: History, Sharp Market Share Gains, and Key Differentiators

By Douglas Kim

  • Since the start of its operations on 4 March, Nextrade (NXT) has rapidly gained its market share to nearly 25% of the total equity trading value in Korea.
  • Although retail investors account for about 95% of total trading value at NXT, there is a growing interest in more institutional investors trading through the Nextrade exchange.
  • High frequency traders as well those trying to capitalize on lower trading transaction fees and alpha generating trading events/news flow in after hour markets are increasingly trading on the NXT.  

Overview #25 Implications of Stronger Asian Currencies

By Rikki Malik

  • A review of recent events/data impacting our investment themes and outlook
  • Regime change comes to Asia, making sector selection key to performance
  • Some key recession watch indicators  continue to ring alarm bells

Asia base oils supply outlook: Week of 5 May

By Iain Pocock

  • Asia’s base oils prices extend rise vs feedstock/gasoil prices.
  • Sustained strength of base oils margins points to limited surplus supply even as firm prices incentivize refiners to boost output.
  • Limited surplus supply at end-Q1/early-Q2 2025 follows seasonal rise in demand and heavy round of plant maintenance.

Vietnam – Hold Don’t Sell Down

By Sharmila Whelan

  • Hold onto Vietnam positions – the economy has held up and the country will negotiate a trade deal with the US. It has no choice but to buckle. 
  • Vietnam’s trade deficit with the US is the fourth largest and the US accounts for 30% of exports.  Trump will force it to lower tariff rates, tighten rules of origin. 
  • But Vietnamese companies aren’t re-locating to the US, there are no critical industries for Trump to target and the US cannot wean itself of Vietnam’s cheap low value-added consumer goods.

Global base oils arb outlook: Week of 5 May

By Iain Pocock

  • Europe Group III base oils price trends higher vs prices in US and Asia over past two months.
  • Europe Group III price trends higher vs domestic Group I price and VGO, holds firm vs domestic Group II price.
  • Europe’s firmer Group III price differentials could reflect correction following sustained weakness.

Global base oils margins outlook: Week of 5 May

By Iain Pocock

  • Global base oils prices extend rise vs feedstock/competing fuel prices.
  • Outright prices mostly hold firm or rise even in face of ongoing dip in crude oil/diesel prices.
  • Contrasting trends point to stronger base oils fundamentals relative to crude/diesel.

Real Asset Chartbook Week #4: Still Interesting

By Massif Capital Research

We will be publishing our 1st Quarter 2025 Letter to Investors next week, the following is an excerpt from that letter:

As we noted earlier this year, we believe, along with many others, that we are now in a period in which investing from the position of political and geopolitical naivety has ended. As such, what has worked in markets is unlikely to work in the future.

This transition has been years in the making. Still, a confluence of events in recent years, starting with COVID and ending most recently with a rollout of an effort by the US government to reshape global trade, has sharply accelerated the transition.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Event-Driven: Canvest (1381 HK): Buy Here and more

By | Daily Briefs, Event-Driven

In today’s briefing:

  • Canvest (1381 HK): Buy Here, And On Weakness
  • HSCEI Earning Revision Analysis (Apr): CCB, Sinopec, BOC, Petrochina, CNOOC, China Overseas, Ping An


Canvest (1381 HK): Buy Here, And On Weakness

By David Blennerhassett

  • Ahead of the 12th May shareholder to vote on Grandblue’s Offer, recent price action in Canvest (1381 HK) has been odd, with considerable selling volume.
  • By all accounts, a chunk of that selling was brought about by an event desk in Singapore shutting down. Elsewhere, via numerous inquiries, I see nothing deal specific. 
  • In recent positive developments, AEP (3.62% of shares out) is supportive; there are no material updates in s329 announcements; and I see nothing of note when inspecting the shareholder register. 

HSCEI Earning Revision Analysis (Apr): CCB, Sinopec, BOC, Petrochina, CNOOC, China Overseas, Ping An

By Ke Yan, CFA, FRM

  • We analysed the earning revision of component stocks of HSCEI in the past month.
  • We tabulated stocks with the top impact on index’s EPS, stocks’ EPS revision, and revenue revision.
  • We highlighted EPS revision on CCB, Sinopec, BOC, Petrochina, CNOOC, China Overseas, Ping An.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief South Korea: Han Kuk Carbon, Studio Dragon, Kolmar Korea , Musinsa and more

By | Daily Briefs, South Korea

In today’s briefing:

  • Errors in Local Street’s Projections for the KOSPI 200 Rebalancing
  • KOSPI200 Index Rebalance Preview: 7 Changes a Side for June
  • A 100% Tariffs on Films Produced Outside the U.S. – Negative on Korean Film Production Companies
  • Kolmar Korea: K-Beauty ODMs- Positioned to Ride US Demand Growth While Tiding Over Tariffs
  • Initial Thoughts on the Musinsa IPO


Errors in Local Street’s Projections for the KOSPI 200 Rebalancing

By Sanghyun Park

  • One local desk misread the KOSPI 200 rules, thinking one screen was enough — but it’s a strict two-step filter, and that led to three wrong delete calls.
  • KRX will drop the rebalance list post-close on May 21 or 22, and despite well-telegraphed outcomes, strong next-day price action has followed in past cycles.
  • Consider a pre-announcement long/short basket trade, as this is the first rebalance post-short-selling resumption. NXT’s rising market share also creates opportunities in overnight-daytime price spreads.

KOSPI200 Index Rebalance Preview: 7 Changes a Side for June

By Brian Freitas

  • With the review period complete, there could be 7 changes for the Korea Stock Exchange KOSPI 200 (KOSPI2 INDEX) in June.
  • The impact on the potential inclusions ranges from 1.6-22 days of ADV while the impact on the potential deletions varies from 3.6-16.5 days of ADV.
  • Han Kuk Carbon (017960 KS) appeared as a forecast add in the week starting 22 March and the stock is up 38% since then.

A 100% Tariffs on Films Produced Outside the U.S. – Negative on Korean Film Production Companies

By Douglas Kim

  • The Trump administration proposed a new 100% tariffs at movies produced outside the United States. Korean contents account for about 8-9% of total viewing hours on Netflix globally.
  • Top three listed film/drama production companies in Korea including Studio Dragon, CJ ENM, and ContentreeJoongAng are likely to be negatively impacted by the new major tariffs imposed by the U.S.
  • Economics of making a movie is much cheaper in South Korea versus the U.S. Producing a film in South Korea can cost 30–70% less than in the United States.

Kolmar Korea: K-Beauty ODMs- Positioned to Ride US Demand Growth While Tiding Over Tariffs

By Devi Subhakesan

  • K-Beauty ODM segment appears positioned both to ride the secular growth of Korean skincare in the U.S. and to tide over tariff turbulence given their US based manufacturing facilities.
  • By contrast to OEM/ODM players, major legacy consumer beauty brands like AmorePacific, LG Household & Health Care have been slower to localise production leaving them exposed to reciprocal tariffs.
  • With American cosmetic imports from Korea hitting all-time highs, Korean ODMs with local facilities could see demand growth and profit recovery as clients onshore production to avoid tariffs.

Initial Thoughts on the Musinsa IPO

By Douglas Kim

  • Musinsa is getting ready to complete its IPO in 2H 2025. Musinsa is the top fashion online/mobile platform in Korea. 
  • The market value of Musinsa is expected to be about 5 trillion won which could be one of the largest IPOs in Korea this year. 
  • Musinsa had its best ever results in 2024 with sales of 1.2 trillion won (up 25.1% YoY), operating profit of 102.8 billion won, and net profit of 69.8 billion won.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief China: Sonoscape Medical Corp, Tencent, Kuang-Chi Technologies , Canvest Environmental Protection Group, Chery Automobile, Busy Ming Group, Jiangsu Hengrui Medicine, Hang Seng China Enterprises Index, Contemporary Amperex Technology (CATL), TAL Education and more

By | China, Daily Briefs

In today’s briefing:

  • Quiddity Leaderboard ChiNext & ChiNext 50 Jun25: Last-Minute Methodology Changes; Final Expectations
  • Asian Equities: Currency Strength Driving FII Flows – Winners and Losers
  • CSI300 Index Rebalance Preview: 8 Changes a Side in June; US$4.5bn Trade
  • Canvest (1381 HK): Buy Here, And On Weakness
  • Chery Auto Pre-IPO – The Negatives – Small NEV Portfolio
  • Busy Ming IPO: Hyper Growth and Solid Profitability, Largest Snack and Beverage Retailer in China
  • Jiangsu Hengrui Pharma H Share Listing: The Investment Case
  • HSCEI Earning Revision Analysis (Apr): CCB, Sinopec, BOC, Petrochina, CNOOC, China Overseas, Ping An
  • CATL A/H Listing – PHIP Updates and Updated Thoughts on A/H Premium
  • TAL Education Group: Innovation in Learning Devices


Quiddity Leaderboard ChiNext & ChiNext 50 Jun25: Last-Minute Methodology Changes; Final Expectations

By Janaghan Jeyakumar, CFA

  • The ChiNext index represents the performance of the 100 largest and most liquid A-share stocks listed on the ChiNext Market of the Shenzhen Stock Exchange.
  • The ChiNext 50 index is a subset of the ChiNext Index and it consists of the top 50 names in the ChiNext index with the highest daily average turnover.
  • In this insight, we have presented our final expectations for the upcoming index rebal event. We expect 9 ADDs/DELs for the ChiNext index and 5 ADDs/DELs for the ChiNext 50.

Asian Equities: Currency Strength Driving FII Flows – Winners and Losers

By Manishi Raychaudhuri

  • The recent spike in Asian currencies is driving foreign institutional flows into Asian equities. Currency appreciation is usually a lead indicator of FII flows, implying that this enthusiasm may continue. 
  • The markets that were sold down the most are attracting the most flows and could continue to do so. India, Taiwan and to a lesser extent, Korea qualify.
  • Domestic sectors like Chinese internet, restaurant chains, athleisure; Indian private banks, consumer discretionary, hospital chains could gain. So could defensives with high dividend yields, e.g. Korea and Chinese utilities, telecom.

CSI300 Index Rebalance Preview: 8 Changes a Side in June; US$4.5bn Trade

By Brian Freitas

  • There could be 8 changes at the June rebalance with the Industrials and Information Technology sectors gaining 3 index spots each and the Materials sector losing 4 spots.
  • Estimated one-way turnover is 1.44% at the rebalance leading to a round-trip trade of CNY 32.55bn (US$4.5bn). There are 13 stocks with over 2x ADV to trade.
  • The forecast adds have outperformed the forecast deletes over the last 6 weeks even though there have been large ETF creations. There could be more outperformance coming up.

Canvest (1381 HK): Buy Here, And On Weakness

By David Blennerhassett

  • Ahead of the 12th May shareholder to vote on Grandblue’s Offer, recent price action in Canvest (1381 HK) has been odd, with considerable selling volume.
  • By all accounts, a chunk of that selling was brought about by an event desk in Singapore shutting down. Elsewhere, via numerous inquiries, I see nothing deal specific. 
  • In recent positive developments, AEP (3.62% of shares out) is supportive; there are no material updates in s329 announcements; and I see nothing of note when inspecting the shareholder register. 

Chery Auto Pre-IPO – The Negatives – Small NEV Portfolio

By Sumeet Singh

  • Chery Automobile is looking to raise about US$1bn in its upcoming Hong Kong IPO.
  • Chery Auto is a Chinese passenger vehicle company which designs, develops, manufactures and sells passenger vehicles, including internal combustion engine vehicles and new energy vehicles, both domestically and overseas.
  • In this note, we talk about the not-so-positive aspects of the deal.

Busy Ming IPO: Hyper Growth and Solid Profitability, Largest Snack and Beverage Retailer in China

By Andrei Zakharov

  • Busy Ming Group, “a snack brand for the people” and the largest snack and beverage chain retailer in China, filed for an IPO in Hong Kong.
  • The fast-growing retailer was backed by HongShan Capital, Gaorong Ventures, 5Y Capital, Haoxiangni Health Food, and Yanker Shop Food Co., among others.
  • Busy Ming Group is tapping into Gen Z and younger millennial consumers with playful branding and social media engagement.

Jiangsu Hengrui Pharma H Share Listing: The Investment Case

By Arun George

  • Jiangsu Hengrui Medicine (600276 CH), a leading Chinese pharmaceutical company, has filed its PHIP for an H Share listing to raise US$2 billion.     
  • Jiangsu Hengrui Pharmaceuticals (JHR HK) ranked first among Chinese pharma companies in revenue from NME drugs in 2023 and the number of commercialised NME drugs in 2024.
  • The investment case rests on its product portfolio, strong revenue growth, rising profitability, cash generation, strong balance sheet and undemanding valuation. 

HSCEI Earning Revision Analysis (Apr): CCB, Sinopec, BOC, Petrochina, CNOOC, China Overseas, Ping An

By Ke Yan, CFA, FRM

  • We analysed the earning revision of component stocks of HSCEI in the past month.
  • We tabulated stocks with the top impact on index’s EPS, stocks’ EPS revision, and revenue revision.
  • We highlighted EPS revision on CCB, Sinopec, BOC, Petrochina, CNOOC, China Overseas, Ping An.

CATL A/H Listing – PHIP Updates and Updated Thoughts on A/H Premium

By Sumeet Singh

  • Contemporary Amperex Technology (CATL) (300750 CH), one of the world’s largest battery solutions providers, aims to raise around US$5bn in its H-share listing.
  • CATL is the global leader in new energy vehicle battery solutions, in China and globally, as per SNE Research. Its A-shares have been listed since 2018.
  • We have looked at the company’s past performance and valuations in our earlier notes. In this note, we talk about its recent updates and provide updated thoughts on valuations.

TAL Education Group: Innovation in Learning Devices

By Baptista Research

  • TAL Education Group’s latest quarter and fiscal year performance presents a mixed picture, with notable expansions alongside challenges in profitability.
  • Key areas such as Learning Services and Content Solutions have shown significant revenue growth, demonstrating the company’s efforts to broaden its educational offerings.
  • In fiscal 2025, TAL Education Group recorded a considerable increase in net revenues, reaching USD 2.3 billion, a 51% rise from the previous year.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Most Read: Contemporary Amperex Technology (CATL), Toyota Industries, NetEase , Hanwha Ocean , Nan Ya Plastics, Sonoscape Medical Corp, Guangzhou Automobile Group, Han Kuk Carbon and more

By | Daily Briefs, Most Read

In today’s briefing:

  • CATL A/H Listing – Thoughts on A/H Premium
  • Toyota Industries (6201) – Thinking About How To Value a ¥6trln Bid
  • Hang Seng Indexes: ADR Depositary Holding Changes; Round-Trip Trade Is US$5.1bn; NetEase Outperforms
  • CATL H Share Listing: AH Discount Views
  • Rare Arb Opportunity from ATS Breakout in Korea: Day-Night Spread
  • Quiddity Leaderboard TDIV Jun25: US$2.5bn One-Way; Several High-Impact Flow Names
  • Quiddity Leaderboard ChiNext & ChiNext 50 Jun25: Last-Minute Methodology Changes; Final Expectations
  • A/H Premium Tracker (To 2 May 2025):  AH Premia Fall Small; Spread Torsion Provides Continued Alpha
  • Errors in Local Street’s Projections for the KOSPI 200 Rebalancing
  • HEM: Dovish Prices Deranged


CATL A/H Listing – Thoughts on A/H Premium

By Sumeet Singh

  • Contemporary Amperex Technology (CATL) (300750 CH), one of the world’s largest battery solutions providers, aims to raise at least US$5bn in its H-share listing.
  • CATL is the global leader in new energy vehicle battery solutions, in China and globally, as per SNE Research. Its A-shares have been listed since 2018.
  • We have looked at the company’s past performance in our earlier notes. In this note, we talk about its recent updates and provide our thoughts on valuations.

Toyota Industries (6201) – Thinking About How To Value a ¥6trln Bid

By Travis Lundy

  • Toyota Industries is a relatively complicated business. It owns lots of shares of Toyota and other companies. It has a financing business, and runs ¥500+bn of EBITDA.
  • As of 31 March 2025, the “Enterprise Value” of the Operating and Financing Business together was about ¥2.2trln. The “Asset Ownership Business” was at ¥2.8trln (1yr ago it was ¥4trln).
  • If you think buying the Operating Business at 6x EBITDA is appropriate, that means the Asset Ownership Business block buy gets done at 31-March-2025 prices. Worth thinking about.

Hang Seng Indexes: ADR Depositary Holding Changes; Round-Trip Trade Is US$5.1bn; NetEase Outperforms

By Brian Freitas

  • Most Secondary-listed companies have announced the number of shares that underlie ADRs and are held by the ADR depositaries as of end-March (or around that time).
  • There are some significant increases in the number of shares held by the ADR depositaries. That changes the free float for the stocks and consequently the estimated flows.
  • NetEase (9999 HK), Trip.com Group (9961 HK), Baidu (9888 HK) and Weibo (9898 HK) will have passives buying, while NIO (9866 HK) switches to a sell.

CATL H Share Listing: AH Discount Views

By Arun George

  • Contemporary Amperex Technology (CATL) (300750 CH), the world’s largest supplier of EV and ESS batteries, is set to launch an H Share listing to raise US$5 billion.
  • In CATL H Share Listing: The Investment Case, a leading market position, forecasted return to growth, peer-leading profitability, cash generation, peer-leading FCF margin and an attractive valuation are highlighted.  
  • In this note, I examine the likely discount CATL will offer its H Shares compared to the A Shares.

Rare Arb Opportunity from ATS Breakout in Korea: Day-Night Spread

By Sanghyun Park

  • Local traders are targeting the spread between day and NXT’s after-hours, a classic arb play similar to what Japanese instos used when ATS first launched, now emerging in Korea.
  • The gap persists because institutional flow on NXT is still minimal, with recent data showing instos accounting for just 1-2% of total turnover.
  • NXT’s night session is seeing heavy retail flow, providing instos with the liquidity to trade. This creates a rare opportunity to capitalize on early inefficiencies before others catch on.

Quiddity Leaderboard TDIV Jun25: US$2.5bn One-Way; Several High-Impact Flow Names

By Janaghan Jeyakumar, CFA

  • The TDIV index tracks the top 50 names in the Taiwan Stock Exchange with the highest dividend yields. It is a yield-weighted index with unique capping rules.
  • In this insight, we take look at Quiddity’s expectations for index changes and capping flows for the TDIV Index for the June 2025 index rebal event.
  • We expect five changes for the TDIV index and there could be index flows of US$2.5bn one-way due to capping.

Quiddity Leaderboard ChiNext & ChiNext 50 Jun25: Last-Minute Methodology Changes; Final Expectations

By Janaghan Jeyakumar, CFA

  • The ChiNext index represents the performance of the 100 largest and most liquid A-share stocks listed on the ChiNext Market of the Shenzhen Stock Exchange.
  • The ChiNext 50 index is a subset of the ChiNext Index and it consists of the top 50 names in the ChiNext index with the highest daily average turnover.
  • In this insight, we have presented our final expectations for the upcoming index rebal event. We expect 9 ADDs/DELs for the ChiNext index and 5 ADDs/DELs for the ChiNext 50.

A/H Premium Tracker (To 2 May 2025):  AH Premia Fall Small; Spread Torsion Provides Continued Alpha

By Travis Lundy

  • A quiet week as most indices – HK and mainland – saw performance hover around zero for the three days both were open at the start of the week. 
  • For a couple of months I’ve thought warning signs were flashing and spreads could widen. Widening has paused. I am not comfortable it will remain paused or Hs will outperform.
  • The Quiddity Portfolio is pretty hunkered down and nearly flat H/A risk. But benefits from spread torsion (wider spreads coming in, small premia widening). Alpha good again this week.

Errors in Local Street’s Projections for the KOSPI 200 Rebalancing

By Sanghyun Park

  • One local desk misread the KOSPI 200 rules, thinking one screen was enough — but it’s a strict two-step filter, and that led to three wrong delete calls.
  • KRX will drop the rebalance list post-close on May 21 or 22, and despite well-telegraphed outcomes, strong next-day price action has followed in past cycles.
  • Consider a pre-announcement long/short basket trade, as this is the first rebalance post-short-selling resumption. NXT’s rising market share also creates opportunities in overnight-daytime price spreads.

HEM: Dovish Prices Deranged

By Phil Rush

  • Despite concerns, activity continues to be robust with stable manufacturing and tight labour markets.
  • There is a persistent issue of high underlying price and wage inflation.
  • The Bank of England’s rate cut ahead of the Federal Reserve is seen as highly irrational, as rates do not reflect the rebounding risk sentiment.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Analytics and News
  • ✓ Events & Webinars



Daily Brief United States: Base Oil, Apple , Advanced Micro Devices, Cerberus Cyber Sentinel, Lantern Pharma , Mira Pharmaceuticals , Phillips 66 and more

By | Daily Briefs, United States

In today’s briefing:

  • Asia base oils supply outlook: Week of 5 May
  • APPLE (AAPL US) Post-Earnings Outlook: A Potential Tactical Buy
  • Global base oils arb outlook: Week of 5 May
  • Global base oils margins outlook: Week of 5 May
  • AMD: 1Q25 Small Beat, 2Q Would Have Been a Large Beat Except for New US Export Restrictions to China
  • CISO: Leading cybersecurity provider entering new growth phase with high margin
  • CISO: Leading cybersecurity provider entering new growth phase with high margin
  • LTRN: IND Clearance for LP-184 in TNBC
  • MIRA: Breakthrough Results for Pain Treatment
  • Phillips 66: Its Expansion & Integration of Midstream Operations With A Focus On NGLs Might Just Pay Off!


Asia base oils supply outlook: Week of 5 May

By Iain Pocock

  • Asia’s base oils prices extend rise vs feedstock/gasoil prices.
  • Sustained strength of base oils margins points to limited surplus supply even as firm prices incentivize refiners to boost output.
  • Limited surplus supply at end-Q1/early-Q2 2025 follows seasonal rise in demand and heavy round of plant maintenance.

APPLE (AAPL US) Post-Earnings Outlook: A Potential Tactical Buy

By Nico Rosti

  • Apple (AAPL US) started a mild pullback after releasing its earnings on May 1st. We think this pullback may be a BUY opportunity.
  • Some analysts believe the Trump administration’s tariffs will ultimately prove transitory. While near-term impacts are surely expected for Apple (AAPL US) , they’re probably short-term in nature.
  • Our model suggests a potential buying opportunity in Apple (AAPL US) may be approaching. This insight outlines the tactical considerations behind that view.

Global base oils arb outlook: Week of 5 May

By Iain Pocock

  • Europe Group III base oils price trends higher vs prices in US and Asia over past two months.
  • Europe Group III price trends higher vs domestic Group I price and VGO, holds firm vs domestic Group II price.
  • Europe’s firmer Group III price differentials could reflect correction following sustained weakness.

Global base oils margins outlook: Week of 5 May

By Iain Pocock

  • Global base oils prices extend rise vs feedstock/competing fuel prices.
  • Outright prices mostly hold firm or rise even in face of ongoing dip in crude oil/diesel prices.
  • Contrasting trends point to stronger base oils fundamentals relative to crude/diesel.

AMD: 1Q25 Small Beat, 2Q Would Have Been a Large Beat Except for New US Export Restrictions to China

By Nicolas Baratte

  • Good 1Q25, revenue +36% YoY, EPS +55%. Complicated 2-3Q ahead due to US export restrictions cutting down revenue by 1.5bn. This is a one-off. Ignoring this, underlying growth looks strong.   
  • AMD is gaining share in PC and Server, incl enterprise. GPU offering is still behind Nvidia but improving with MI350 in mid-25, MI400 mid-26. MI400 should be on-par with NVDA.
  • The stock is down -45% from Jan-24. Trading on low multiples versus historicals: 17x 2026 EPS or more than -1 stdev below avg. Buy!



LTRN: IND Clearance for LP-184 in TNBC

By Zacks Small Cap Research

  • Zacks Small-Cap Research Note for Lantern Pharma, Inc. (LTRN)

MIRA: Breakthrough Results for Pain Treatment

By Zacks Small Cap Research

  • MIRA Pharmaceuticals(MIRA) Company Sponsored Research Report

Phillips 66: Its Expansion & Integration of Midstream Operations With A Focus On NGLs Might Just Pay Off!

By Baptista Research

  • Phillips 66’s first quarter 2025 earnings overview reflects both strategic advancements and current operational challenges faced by the company.
  • Mark Lashier, the Chairman and CEO, emphasized the company’s focus on executing its transformational strategy despite a challenging macro-economic environment in the Refining, Renewables, and Chemicals segments.
  • The company reported $487 million in earnings but an adjusted loss of $368 million, attributing this to factors such as accelerated depreciation and the impact of significant turnaround activities, which temporarily affected volumes and margins.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief India: Adani Power, Sagility India, Nuvoco Vistas , Adani Ports & Special Economic Zone, Associated Alcohol & Breweries, JSW Steel Ltd and more

By | Daily Briefs, India

In today’s briefing:

  • Adani Power: Navigating Challenges
  • Sagility India IPO Lockup – US$1.5bn Lockup Release; PE Promoter Will Have to Trim for Free-Float
  • Nuvoco Vistas: Improving Performance and Strategic Expansion
  • Adani Ports – Earnings Flash – FY 2024-25 Results – Lucror Analytics
  • Business Breakdown: Associated Alcohols- The Spirit of Bold Expansion
  • JSW Steel–BPSL Acquisition: Court Verdict, Strategic Importance, and Investment Implications


Adani Power: Navigating Challenges

By Rahul Jain

  • Adani Power delivered strong FY25 earnings and plans to expand capacity to 30.7 GW by FY30 through brownfield, greenfield, and acquisition-driven growth.
  • Godda, Jharkhand (110km from Bangladesh) project supports high realisations, but Bangladesh receivable buildup (~USD 900 million) remains a working capital risk, with gradual collections ongoing.
  • Adani Power offers strong margins, improving ROCE, and trades at ~16.6× FY25 P/E.

Sagility India IPO Lockup – US$1.5bn Lockup Release; PE Promoter Will Have to Trim for Free-Float

By Akshat Shah

  • Sagility India (2058883D IN) (Sagility) raised around US$250m in its India IPO in Nov 2024. The lockup on its pre-IPO investors is set to expire soon.
  • Sagility is a pure-play healthcare focused solutions and services provider to Payers (U.S. health insurance companies), and Providers (primarily hospitals, physicians, and diagnostic and medical devices companies).
  • In this note, we will talk about the lockup dynamics, possible placement and updates since our last note.

Nuvoco Vistas: Improving Performance and Strategic Expansion

By Rahul Jain

  • Nuvoco reported improved volumes, margins, and deleveraging in FY25, with continued focus on cost optimization and operational efficiency.
  • The Vadraj Cement acquisition expands capacity to 31 MTPA, diversifying regional exposure and strengthening presence in Gujarat and Maharashtra – west region.
  • Valuations are reasonable at ~16x FY27E earnings and ~Rs5,100/ton EV/ton, but upside depends on timely integration and ramp-up of new assets.

Adani Ports – Earnings Flash – FY 2024-25 Results – Lucror Analytics

By Leonard Law, CFA

  • Adani Ports and Special Economic Zone (APSEZ) has released FY 2024-25 results that were largely stable y-o-y.
  • Although cargo volume growth underperformed expectations, revenue rose 14% in line with projections, while the 16% EBITDA increase exceeded guidance.
  • APSEZ generated slightly positive FCF, and net adjusted leverage was stable at an acceptable 2.8x.

Business Breakdown: Associated Alcohols- The Spirit of Bold Expansion

By Sudarshan Bhandari

  • AABL is entering premium segments with new products like gin, whisky, and tequila marking a shift from mass-market to value-added growth. 
  • This matters as it boosts margin potential and strengthens brand equity amid rising premium liquor demand.
  • Our view shifts positively on AABL’s long-term strategy, despite near-term risks in regulation and corporate governance.

JSW Steel–BPSL Acquisition: Court Verdict, Strategic Importance, and Investment Implications

By Rahul Jain

  • Supreme Court reinstated strict NCLT terms on May 2, 2025, requiring JSW to fully comply or risk BPSL liquidation; NCLAT relaxations were overturned.
  • BPSL contributes ~12% of JSW’s capacity and ~10% of EBITDA, with strong operational synergy potential, strategic location, and upcoming captive iron ore integration.
  • While management is yet to formally decide, JSW is likely to comply; the ~6% correction offers a strong long-term opportunity as BPSL integration strengthens margins.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars